A clinical trial treating the papillomaviruses responsible for genital warts was on target at the halfway mark, according to Australian of the Year 2006 Professor Ian Frazer and trial manager, sexual health specialist Dr David Jardine.
Nearly a quarter of a million Americans each year may be hospitalized with bleeding complications caused by needlessly taking a daily dose of an adult-sized aspirin rather than a baby aspirin to prevent a heart attack or stroke.
An immune system component that is a primary cause of bone destruction and inflammation in autoimmune diseases such as rheumatoid arthritis actually protects bone in the oral cavity from infectious pathogens that play a major role in periodontal disease in humans, research at the University at Buffalo has shown.
Researchers at the University of Illinois at Chicago College of Pharmacy have received a $1.7 million five-year federal grant to develop a new approach to treat brain tumors.
US Bill Clinton announced new agreements that significantly lower the price of AIDS treatment for second-line anti-retroviral drugs (ARVs), drugs required in patients who develop resistance to first-line treatment and which currently cost 10 times the price of first-line therapy.
Approximately 4.4 percent of US adults may have some form of bipolar disorder during some point in their lifetime, including about 2.4 percent with a “sub-threshold” condition, according to an article in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
A new study in mice raises a tantalizing possibility — that humans may one day be able to eat any kind of fat they want without raising their risk of heart disease.
Everyday experience and psychology research both indicate that paying close attention to one thing can keep you from noticing something else. However, a new study from the University of Wisconsin-Madison suggests that attention does not have a fixed capacity — and that it can be improved by directed mental training, such as meditation.
The likelihood of developing bipolar disorder depends in part on the combined, small effects of variations in many different genes in the brain, none of which is powerful enough to cause the disease by itself, a new study shows. However, targeting the enzyme produced by one of these genes could lead to development of new, more effective medications.
Researchers have found a better way to predict self-injurious behavior by using a test that does not rely on the individual to articulate their thoughts, but instead assesses their implicit attitudes towards self-injury. This procedure addresses a major challenge in the identification of people who engage in self-injurious behavior, because such individuals are often intentionally uncommunicative in order to avoid unwanted treatment as well as unable to articulate their feelings.